The Medical and Regulatory Affairs team at Novo Nordisk oversees the development, dissemination, and enforcement of medical guidelines and regulatory compliance within the company’s global operations. This team ensures that all pharmaceutical products, particularly those aimed at diabetes, obesity, rare diseases, and other chronic conditions, meet rigorous safety and efficacy standards while navigating the complex landscape of international medical regulations. They work collaboratively to facilitate clinical trials, secure regulatory approvals, manage patient access programs, and uphold corporate compliance and privacy standards.
Amie Phillips Pablo
Vice President, Corporate Comp...
Amit Kumar Das
Senior Director - HR I Member ...
Atika Shaheer
Director Medical And Regulator...
Ekta Patel
Clinical Site And Start-up Ass...
Gabriel Martino
Senior International Medical M...
Jeppe Gerner Gullits
Director & Head Of Dd&it Strat...
Joanne Nash
PA To Senior Vice President, G...
Katarina Thor
Vice President, Clinical Quali...
Lisa-Marie Lefebvre
Associate Director, Patient Ac...
Marcin Zychma
Vice President, Medical Affair...
Marie Louise Hede
Director (head Of Indirect Tax...
Maryanne Santilli
Executive Director - Operation...
Mieke Vancoillie
Clinical Operations Head
Morten Hansen
Vice President, Rare Disease T...
Ognenka Kozar
Corporate Vice President Clini...
Rebekka Dam-Tuxen
Vice President Project
Richard Easom
Executive Medical Liaison
Rikke Lohse
Global Portfolio Project Lead,...
Shawn Beasley
Vice President Quality
Sjoukje Slofstra
Manager Medical Affairs
Stephen Gough
Global Chief Medical Officer
Tu Xu
Director Of Biostatistics
View all